Pharmaceuticals
LATEST
Patent | Regulatory & Compliance
New Praise, and Pressure, For the Pharma Industry
Amy Fix, partner at Barnes & Thornburg, discusses the effects of the COVID-19 pandemic on the pharmaceutical industry, including the ways that health and safety protocols have affected the R&D process, the pandemic’s impact on the patent and regulatory landscapes, and what the future of the industry may look like.
Read MoreMore Pharmaceuticals Articles
Pharmaceuticals
New Praise, and Pressure, For the Pharma Industry
Amy Fix, partner at Barnes & Thornburg, discusses the effects of the COVID-19 pandemic on the pharmaceutical industry, including the ways that health and safety protocols have affected the R&D process, the pandemic’s impact on the patent and regulatory landscapes, and what the future of the industry may look like.
Read MorePharmaceuticals
Life Sciences Litigation Heats Up Around Patent Eligibility And Generics
Fish & Richardson patent litigator Betsy Flanagan talks about the latest trends in high-stakes patent litigation for pharmaceutical companies and the importance of fostering more teams led by women.
Read MorePharmaceuticals
As Opioid Suits Loom, Now’s the Time to Act on D&O Insurance
Coverage for opioid exposures remains relatively untested, with existing case law increasing the uncertainty.
Litigation related to to the opioid crisis is on the rise, and now corporate shareholders are entering the fray. In recent months, shareholders have brought a number of lawsuits...
Read More